Skip to main content
. Author manuscript; available in PMC: 2021 Jan 26.
Published in final edited form as: J Am Med Dir Assoc. 2020 Dec 9;22(6):1317–1321.e2. doi: 10.1016/j.jamda.2020.11.010

Fig. 1.

Fig. 1.

Percentage of NHs that received at least 1 deficiency for F880: Infection Prevention and Control from 2017 to 2019. Of US NHs, 57% (n = 8464) received at least 1 F880 deficiency over 2 years. Cumulative incidence was lowest in North Carolina at 19.85% and highest in West Virginia at 78.50%.